Hasil Pencarian - Gunnar Brobert

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registers

    Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from nati... oleh Venkatesh Kumar Gurusamy, Gunnar Brobert, Pareen Vora, Leif Friberg

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

    Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden oleh Yanina Balabanova, Bahman Farahmand, Pär Stattin, Hans Garmo, Gunnar Brobert

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

    Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden oleh Hans Garmo, Yanina Balabanova, Gunnar Brobert, Pär Stattin, Bahman Farahmand

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Overall survival and second primary malignancies in men with metastatic prostate cancer.

    Overall survival and second primary malignancies in men with metastatic prostate cancer. oleh Juha Mehtälä, Jihong Zong, Zdravko Vassilev, Gunnar Brobert, Montse Soriano Gabarró, Pär Stattin, Houssem Khanfir

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care

    Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–co... oleh Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Gunnar Brobert, Samuel Fatoba, María Eugenia Sáez, Antonio González-Pérez

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

    Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands oleh Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ron M. C. Herings, Tania Schink, Ulrike Haug

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

    Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. oleh Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults

    Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults oleh Natalie Ebert, Alice Schneider, Doerte Huscher, Nina Mielke, Yanina Balabanova, Gunnar Brobert, Carla Lakenbrink, Martin Kuhlmann, Anne-Katrin Fietz, Markus van der Giet, Volker Wenning, Elke Schaeffner

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

    Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe oleh Luis Alberto García Rodríguez, Montse Soriano-Gabarró, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ana Ruigomez, Leif Friberg, Ron Herings, Karin M A Swart, Tania Schink, Elisabeth Smits, Annemarie Voss, Christine Tarenz, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program

    Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program oleh Kimberly Snow Caroti PharmD, Alok A. Khorana MD, Cecilia Becattini MD, Agnes Y.Y. Lee MD, Anders Ekbom MD, Marc Carrier MD, Alexander T. Cohen MD, Christopher Brescia BS, Khaled Abdelgawwad MSc, MBA, George Psaroudakis PhD, Marcela Rivera PhD, Bernhard Schaefer BS, Gunnar Brobert PhD, Craig I. Coleman PharmD

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: